S. Dalai, M. Es-Sayed, M. Nötzel, A. de Meijere
FULL PAPER
General Procedure for the Preparation of Methyl 2Ј-Arylspiro[cyclo-
propane-1,4Ј-oxazoline]-5Ј-carboxylates 3 (GP1): A solution of
methyl 2-chloro-2-cyclopropylideneacetate (1)[1,2] and the respective
carboxamide (1 equiv.) in anhydrous acetonitrile was treated with
1 equiv. of NaH (60% dispersion in mineral oil) at 0 °C. The re-
sulting suspension was subsequently stirred at this temperature for
1 h and at 20 °C for an additional 1 h. After removal of the solvent,
the pale yellow residue was taken up with diethyl ether (300 mL)
and the solution washed with water (100 mL). The aq. layer was
extracted with diethyl ether (2ϫ100 mL), and the combined or-
ganic phases were dried with MgSO4. The solvents were evaporated
under reduced pressure, and the crude product was purified by col-
umn chromatography.
(185 mg, 0.85 mmol), H OAt (139 mg, 1.02 mmol), ED C·H Cl
(244 mg, 1.27 mmol), 2,4,6-collidine (206 mg, 1.70 mmol) and 5-
chloro-2-hydroxyaniline (146 mg, 1.1 mmol) in CH2Cl2 (15 mL) ac-
cording to GP3 was purified by column chromatography (Rf =
0.25; pentane/Et2O, 1:1) to yield 268 mg (92%) of 5aa as a colorless
solid, m.p. 211 °C. IR (KBr): ν = 3381 , 3052, 1668, 1558, 1431,
˜
1339, 1195, 1033 cm–1. 1H NMR (300 MHz, CDCl3): δ = 0.96–1.18
(m, 2 H, cPr-H), 1.34–1.50 (m, 2 H, cPr-H), 5.01 (s, 1 H, CH),
6.87–6.92 (m, 1 H, Ar-H), 7.05 (dd, 3J = 8.2, 4J = 2.5 Hz, 1 H,
aryl-H) 7.42–7.58 (m, 3 H, aryl-H), 7.77 (s, 1 H, aryl-H), 7.96–8.00
(m, 2 H, aryl-H), 8.27 (br. s, 1 H, NH) ppm. 13C NMR (75.5 MHz,
CDCl3, APT): δ = 10.6 (–, cPr-C), 14.5 (–, cPr-C), 53.7 (–, cPr-C),
80.2 (+, CH-C), 120.1 (+, aryl-C), 121.9 (+, aryl-C), 125.5 (–, aryl-
C), 126.6 (–, aryl-C), 127.0 (+, aryl-C), 127.9 (+, 2 C, aryl-C), 128.7
(+, 2 C, aryl-C), 131.9 (+, aryl-C), 146.8 (–, aryl-C), 161.5 (–, CN-
C), 168.2 (–, CO-C) ppm. MS (70 eV): m/z (%) = 344/342 (6/20)
[M+], 200 (55), 173 (100), 172 (58), 105 (54). C18H15ClN2O3 (342.8):
calcd. C 63.07, H 4.41, N 8.17; found C 63.32, H 4.18, N 8.02.
Methyl
5-Phenyl-6-oxa-4-azaspiro[2.4]hept-4-ene-7-carboxylate
(3a): The crude product obtained from 1 (2.50 g, 17.0 mmol),
benzamide (2a, 5.20 g, 17.0 mmol) and NaH (595 mg, 17.0 mmol)
in anhydrous acetonitrile (50 mL) according to GP1 was purified
by column chromatography (Rf
3ϫ10 cm) to yield 2.2 g (54%) of 3a as a colorless solid, m.p.
48 °C. IR (KBr): ν = 2948, 1732, 1449, 1284, 1057, 694 cm–1 1H
= 0.38; pentane/Et2O, 4:1;
General Procedure (GP4) for the Preparation of (Benzoxazolyl)-
oxazolines 6: A solution of DEAD (2.2 equiv.) was added drop-
wise to a solution of the respective anilide 5 (1 equiv.) and Ph3P
(2.2 equiv.) in anhydrous THF (10 mL) in an ice bath, and the mix-
ture was stirred at 20 °C for 10 h. To the reaction mixture were
added Et2O (25 mL) and H2O (80 mL), and the organic layer was
separated. The aq. layer was extracted with Et2O (2ϫ25 mL), the
combined ethereal layers were dried with MgSO4 and concentrated,
and the residue was purified by column chromatography to yield
the corresponding benzoxazoles.
.
˜
NMR (250 MHz, CDCl3): δ = 0.91–1.08 (m, 2 H, cPr-H), 1.18–
1.27 (m, 1 H, cPr-H), 1.32–1.42 (m, 1 H, cPr-H), 3.80 (s, 3 H, CH3),
4.93 (s, 1 H, CH), 7.39–7.54 (m, 3 H, aryl-H), 7.91–7.99 (m, 2 H,
aryl-H) ppm. 13C NMR (50.3 MHz, CDCl3, APT): δ = 10.4 (–,
cPr-C), 14.7 (–, cPr-C), 52.3 (+, CH3), 53.3 (–, cPr-C), 79.7 (+, CH-
C), 127.0 (–, aryl-C), 128.0 (+, 2 C, aryl-C), 128.4 (+, 2 C, aryl-C),
131.5 (+, aryl-C), 163.5 (–, CN-C), 169.5 (–, CO-C) ppm. MS
(70 eV): m/z (%) = 231 (35) [M+], 172 (100) [M+ – CO2Me], 144
(60), 105 (26).
5-Chloro-2-(5-phenyl-6-oxa-4-azaspiro[2.4]hept-4-en-7-yl)benz-
oxazole (6aa): The crude product obtained from 5aa (103 mg,
0.3 mmol), Ph3P (173 mg, 0.66 mmol) and D EAD (115 mg,
0.66 mmol) according to GP4 was purified by column chromatog-
raphy (Rf = 0.35; pentane/Et2O, 5:1) to yield 83 mg (85%) of 6aa
General Procedure for the Hydrolysis of Methyl Spiro[cyclopropane-
1,4Ј-oxazoline]carboxylates 3 (GP2): Aq. NaOH (1 , 5 equiv.) was
added to a solution of the respective methyl oxazolinecarboxylate 3
(1 equiv.) in MeOH/THF (4:1) at room temperature. The resulting
solution was stirred for 30 min, then glacial AcOH (10 equiv.) was
added, the mixture stirred for an additional 15 min, and the solvent
evaporated in vacuo. The residue was filtered through a pad of SiO2
gel (Et2O/AcOH, 50:1) and the product crystallized from ether/hex-
ane.
as a colorless solid, m.p. 129 °C. IR (KBr): ν = 3077 , 2971, 1653,
˜
1569, 1427, 1335, 1293, 1078, 698 cm–1 1H N MR (300 MH z,
.
CDCl3): δ = 0.54–0.63 (m, 1 H, cPr-H), 0.98–1.06 (m, 1 H, cPr-H),
1.18–1.28 (m, 1 H, cPr-H), 1.36–1.45 (m, 1 H, cPr-H), 5.70 (s, 1 H,
CH), 7.28–7.39 (m, 1 H, aryl-H), 7.40–7.57 (m, 4 H, aryl-H), 7.69
(s, 1 H , aryl-H ), 7.95–8.02 (m, 2 H , aryl-H ) ppm. 13C N M R
(75.5 MHz, CDCl3, APT): δ = 11.1 (–, cPr-C), 14.7 (–, cPr-C), 54.2
(–, cPr-C), 77.8 (+, CH-C), 111.9 (+, aryl-C), 120.4 (+, aryl-C),
126.1 (+, aryl-C), 126.8 (–, aryl-C), 128.1 (+, 2 C, aryl-C), 128.5
(+, 2 C, aryl-C), 130.2 (–, aryl-C), 131.6 (+, aryl-C), 141.5 (–, aryl-
C), 149.5 (–, aryl-C), 163.2 (–, CN-C), 163.7 (–, CN-C) ppm. MS
(70 eV): m/z (%) = 325/323 (2/8) [M+], 172 (16), 155 (100), 105 (18),
91 (82). C18H13ClN2O2 (324.8): calcd. C 66.57, H 4.03, N 8.63;
found C 66.58, H 3.84, N 8.55.
5-Phenyl-6-oxa-4-azaspiro[2.4]hept-4-ene-7-carboxylic Acid (4a):
From 3a (3.40 g, 14.7 mmol), NaOH (2.96 g, 74 mmol) and AcOH
(8.80 g, 147 mmol) in MeOH/THF (200 mL) according to GP2 (Rf
= 0.40; Et2O/AcOH, 50:1), 5.10 g (93%) of 4a was obtained as a
colorless solid, m.p 182 °C. IR (KBr): ν = 3061 , 3009, 1717, 1638,
˜
1
1457, 1364, 1211, 1069, 735 cm–1. H NMR (250 MHz, CD3OD):
δ = 0.95–1.03 (m, 1 H, cPr-H), 1.05–1.34 (m, 3 H, cPr-H), 4.99 (s,
1 H, CH), 7.40–7.59 (m, 3 H, aryl-H), 7.86–7.98 (m, 2 H, aryl-H)
ppm. 13C NMR (62.9 MHz, CD3OD, DEPT): δ = 11.0 (–, cPr-C),
15.3 (–, cPr-C), 54.0 (Cquat., cPr-C), 81.3 (+, CH-C), 128.3 (Cquat.
,
General Procedure (GP5) for the Buchwald–Hartwig Amination of
(Bromophenyl)oxazolinecarboxanilides 8: An oven-dried Schlenk
flask purged with nitrogen, was charged with Pd2(dba)3 and (Ϯ)-
BINAP in toluene (5 mL). The mixture was heated at 80 °C with
stirring for 5 min to dissolve the BINAP. After cooling, the respec-
tive (bromophenyl)oxazolinecarboxanilide 8 (1 equiv.), the respec-
tive secondary amine (1.5 equiv.), and NaOtBu (1.5 equiv.) were
added, and the mixture was heated at 80 °C for 16 h. After cooling
to room temperature, it was diluted with Et2O (25 mL), filtered,
and concentrated in vacuo. The crude product was purified by col-
umn chromatography.
aryl-C), 129.3 (+, 2 C, aryl-C), 129.9 (+, 2 C, aryl-C), 133.3 (+,
aryl-C), 166.2 (–, CN-C), 172.4 (–, CO-C) ppm. MS (70 eV): m/z
(%) = 217 (48) [M+], 172 (100) [M+ – CO2H], 144 (57), 104 (28).
General Procedure for the Preparation of Oxazolinecarboxanilides 5
and 7 (GP3): To an ice-cold solution of the respective oxazoline-
carboxylic acid 4 (1 equiv.) and HOAt (1.2 equiv.) in anhydrous
CH2Cl2 was added EDC·HCl (1.5 equiv.) in one portion, the mix-
ture was stirred for 15 min, then 2,4,6-collidine (2.0 equiv.) and the
respective aniline (1.3 equiv.) were added. The cooling bath was
removed, and the resulting pale yellow reaction mixture was stirred
at 20 °C for 12 h and filtered through a pad of silica gel. The crude
product was purified by column chromatography.
N-Methyl-5-[4-(morpholin-4-yl)phenyl]-N-[3-(trifluoromethyl)-
phenyl]-6-oxa-4-azaspiro[2.4]hept-4-ene-7-carboxamide (9ca): The
crude product obtained from 8c (90.6 mg, 0.20 mmol), Pd2(dba)3
(3.65 mg), (Ϯ)-BI N A P (3.74 mg), mo r p h o lin e (26.0 m g,
N-(5-Chloro-2-hydroxyphenyl)-5-phenyl-6-oxa-4-azaspiro[2.4]hept-
4-ene-7-carboxamide (5aa): The crude product obtained from 4a
3712
www.eurjoc.org
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2008, 3709–3713